The oncogenic activity of LOXL1-AS1 is mediated by its primary downstream target, the DESC1 protein, which is differentially expressed and downregulated in esophageal squamous cell carcinoma (ESCC) (62). Here, LOXL1 is linked to esophageal squamous cell carcinoma.